Q4 2025 · 13F-HR
M28 Capital Management LPholdings as filed
Filed 2026-02-13 · accession 0000902664-26-000993
$137.6M
Reported value
9
Positions
2025-12-31
Period end
The Brief · M28 Capital Management LP · Q4 2025
AI · grounded in 13F
M28 Capital Management LP reported no changes to its 13F holdings for 2025-12-31 relative to 2025-09-30.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $96.3M | 70.0% | 5,664,548 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $22.8M | 16.6% | 9,248,250 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $4.8M | 3.50% | 161,600 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $4.5M | 3.25% | 67,400 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $4.1M | 2.97% | 1,856,117 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $2.1M | 1.50% | 1,019,498 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $1.4M | 0.98% | 385,680 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $1.1M | 0.82% | 185,100 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $514,337 | 0.37% | 521,059 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.